Ghent University Academic Bibliography

Advanced

No shorter telomeres in subjects with a family history of cardiovascular disease in the Asklepios Study

Tim De Meyer UGent, Caroline Van daele UGent, MARC DE BUYZERE UGent, Simon Denil UGent, Dirk De Bacquer UGent, Patrick Segers UGent, Luc Cooman, Gui De Backer UGent, Thierry Gillebert UGent and Sofie Bekaert UGent, et al. (2012) ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 32(12). p.3076-3081
abstract
Objective : Shorter telomere length is associated with the occurrence of cardiovascular events, but the question of causality is complicated by the intertwined effects of inheritance, aging, and lifestyle factors on both telomere length and cardiovascular disease (CVD). Some studies indicated that healthy offspring of coronary artery disease patients exhibited shorter telomeres than subjects without a family history. Importantly, this result would imply that inheritance of shorter telomeres is a primary abnormality associated with an increased risk of CVD, the so-called Telomere Hypothesis of CVD. Therefore, we aimed at further validating the latter results in the large, population-representative Asklepios Study. Methods and results : Peripheral blood leukocyte telomere length was measured using telomere restriction fragment analysis in the young to middle-aged (approximate to 35-55 years old) Asklepios study population, free from overt CVD, and could be successfully combined with data from the Asklepios Family History Database for 2136 subjects. No shorter telomere length could be found in healthy subjects with a family history of CVD compared with those without. Conclusion : These findings cast serious doubt on the hypothesis that telomere length is shorter in families with an increased risk of CVD and do not support the Telomere Hypothesis of CVD.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
cardiovascular disease, family history, telomere, telomere hypothesis of cardiovascular diseases, Asklepios Study, PREMATURE MYOCARDIAL-INFARCTION, HEART-DISEASE, PATERNAL AGE, RISK-FACTORS, LENGTH, ATHEROSCLEROSIS, LEUKOCYTES, DEATH
journal title
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Arterioscler. Thromb. Vasc. Biol.
volume
32
issue
12
pages
3076 - 3081
Web of Science type
Article
Web of Science id
000311101000032
JCR category
PERIPHERAL VASCULAR DISEASE
JCR impact factor
6.338 (2012)
JCR rank
4/66 (2012)
JCR quartile
1 (2012)
ISSN
1079-5642
DOI
10.1161/ATVBAHA.112.300341
project
Bioinformatics: from nucleotids to networks (N2N)
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
3053799
handle
http://hdl.handle.net/1854/LU-3053799
date created
2012-11-16 13:43:10
date last changed
2015-06-17 10:18:28
@article{3053799,
  abstract     = {Objective : Shorter telomere length is associated with the occurrence of cardiovascular events, but the question of causality is complicated by the intertwined effects of inheritance, aging, and lifestyle factors on both telomere length and cardiovascular disease (CVD). Some studies indicated that healthy offspring of coronary artery disease patients exhibited shorter telomeres than subjects without a family history. Importantly, this result would imply that inheritance of shorter telomeres is a primary abnormality associated with an increased risk of CVD, the so-called Telomere Hypothesis of CVD. Therefore, we aimed at further validating the latter results in the large, population-representative Asklepios Study. 
Methods and results : Peripheral blood leukocyte telomere length was measured using telomere restriction fragment analysis in the young to middle-aged (approximate to 35-55 years old) Asklepios study population, free from overt CVD, and could be successfully combined with data from the Asklepios Family History Database for 2136 subjects. No shorter telomere length could be found in healthy subjects with a family history of CVD compared with those without. 
Conclusion : These findings cast serious doubt on the hypothesis that telomere length is shorter in families with an increased risk of CVD and do not support the Telomere Hypothesis of CVD.},
  author       = {De Meyer, Tim and Van daele, Caroline and DE BUYZERE, MARC and Denil, Simon and De Bacquer, Dirk and Segers, Patrick and Cooman, Luc and De Backer, Gui and Gillebert, Thierry and Bekaert, Sofie and Rietzschel, Ernst},
  issn         = {1079-5642},
  journal      = {ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY},
  keyword      = {cardiovascular disease,family history,telomere,telomere hypothesis of cardiovascular diseases,Asklepios Study,PREMATURE MYOCARDIAL-INFARCTION,HEART-DISEASE,PATERNAL AGE,RISK-FACTORS,LENGTH,ATHEROSCLEROSIS,LEUKOCYTES,DEATH},
  language     = {eng},
  number       = {12},
  pages        = {3076--3081},
  title        = {No shorter telomeres in subjects with a family history of cardiovascular disease in the Asklepios Study},
  url          = {http://dx.doi.org/10.1161/ATVBAHA.112.300341},
  volume       = {32},
  year         = {2012},
}

Chicago
De Meyer, Tim, Van daeleCaroline, Marc De Buyzere, Simon Denil, Dirk De Bacquer, Patrick Segers, Luc Cooman, et al. 2012. “No Shorter Telomeres in Subjects with a Family History of Cardiovascular Disease in the Asklepios Study.” Arteriosclerosis Thrombosis and Vascular Biology 32 (12): 3076–3081.
APA
De Meyer, Tim, Van daeleCaroline, De Buyzere, M., Denil, S., De Bacquer, D., Segers, P., Cooman, L., et al. (2012). No shorter telomeres in subjects with a family history of cardiovascular disease in the Asklepios Study. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 32(12), 3076–3081.
Vancouver
1.
De Meyer T, Van daeleCaroline, De Buyzere M, Denil S, De Bacquer D, Segers P, et al. No shorter telomeres in subjects with a family history of cardiovascular disease in the Asklepios Study. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2012;32(12):3076–81.
MLA
De Meyer, Tim, Van daeleCaroline, Marc De Buyzere, et al. “No Shorter Telomeres in Subjects with a Family History of Cardiovascular Disease in the Asklepios Study.” ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 32.12 (2012): 3076–3081. Print.